The shareholders of DDM Holding AG (First North: DDM), (the “Company”), are hereby convened to the Annual General Meeting (the “AGM”) to be held on Wednesday, 27 May 2015 at 2:00 p.m. CET, at the offices of Homburger AG, Prime Tower, Hardstrasse 201 in Zurich, Switzerland. Shareholders are invited to review the various ways to participate at the AGM and cast their vote. Detailed information on this can be found in the attached Notice of Meeting, also available on the Company’s web site, www.ddm-group.ch. Notification of intention to attend, and related items: Only persons registered in the share register of SIX SIS AG or Euroclear Sweden AB are deemed to be shareholders of the Company. In order to be entitled to participate in, and exercise voting rights at the AGM, holders of DDM shares who are not already registered in the share register must request to be registered with their DDM shares in the share register prior to 22 May 2015, 4:00 p.m. CET (the “Record Date”) as follows: Shareholders must instruct their custodian bank to register them as shareholders in the share register with voting rights by sending an application for registration to DDM Holding AG, c/o SIX SAG AG, Share Register, Baslerstrasse 90, CH-4601 Olten, Switzerland. Please note that the registration process may take time and must be completed by the Record Date. To ensure their registration in time for the AGM, shareholders are therefore kindly invited to issue instructions to their custodian bank as soon as possible. Shareholders who cannot personally attend the AGM may be represented: • by a third person: Shareholders must order an admission card for the proxy by completing and signing the registration/proxy form and returning it to DDM Holding AG, c/o SIX SAG AG, Postfach, CH-4609 Olten, Switzerland, prior to 22 May 2015 or • by the independent proxy: Shareholders must complete and sign the registration/ proxy form and return it to Mr. Daniel Bill, Rechtsanwalt und Notar, MSG Rechtsanwälte & Notare AG, Postfach 4755, CH-6304 Zug, Switzerland prior to the AGM. To the extent that no specific instructions are provided in the registration/proxy form, signature of the form grants general authorization to the independent proxy to vote in favor of the proposals submitted by the Board of Directors. Registration/Proxy form will be available at the Company’s web site and be posted on request to the shareholders that state their address. For the full Notice of the Annual General Meeting, please see the attached PDF -file or visit www.ddm-group.ch. For more information, please visit DDM’s website at www.ddm-group.ch or contact: Anders Antonsson, Investor Relations Mail: a.antonsson@ddm-group.ch | Tel: 46 8 4080 9030 DDM Holding AG (Nasdaq First North Stockholm: DDM) is a multinational investor and manager of distressed assets. Since 2007, the DDM Group has built a successful platform in Eastern Europe, with 2.2 million receivables in nominal value over EUR 1.7 billion. DDM Treasury Sweden AB (publ) (NGM: DDM1) is a subsidiary wholly owned by DDM Holding AG. Pareto Securities is DDM Holding AG’s Certified Adviser.
Notice to attend Annual General Meeting of Shareholders of
Top 10 Most Recent News Articles
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings
The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...
Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report
The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...
Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
Strathcona and Greenfire Set Sights on Major Merger
Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...
Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study
Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...
Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost
Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...
Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move
Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....
Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech
Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...
Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon
A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...
Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue ReadingTop 5 Most Recently Viewed Articles
Abeona Therapeutics' ZEVASKYN Receives FDA Approval, a New Hope
A Revolutionary Breakthrough for Epidermolysis Bullosa In an incredible achievement for the EB community, Abeona Therapeutics has received FDA approval for ZEVASKYN, which is poised to change the landscape for treating Recessive Dystrophic Epidermolysis Bullosa (RDEB). This marks a historic moment as the third FDA-approved treatment for RDEB and the first autologous,...
Continue Reading
Zero Candida Reaches Major Milestone with ZC-001 Device Development
Zero Candida Marks Milestone with ZC-001 Prototype Production Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) has achieved a remarkable milestone in its quest to revolutionize women's health. The company recently announced the commencement of prototype production for its groundbreaking therapeutic device, ZC-001, designed specifically for the treatment of...
Continue Reading
Bitcoin's Future and Market Dynamics: Insights from a Veteran Trader
Cautious Optimism for Bitcoin and Other Cryptocurrencies Pseudonymous veteran trader DonAlt expresses a cautious outlook on leading cryptocurrencies like Bitcoin, Ethereum, and Dogecoin. His insights on market trends reveal an intriguing perspective for investors in these digital assets. Current Market Situation DonAlt has recently shared his thoughts on the performance...
Continue Reading
Alibaba Settles for $433.5 Million in Shareholder Lawsuit
Alibaba Reaches Settlement in Lawsuit Alibaba (NYSE: BABA), China’s leading e-commerce powerhouse, has recently taken a significant step in addressing legal challenges by agreeing to pay $433.5 million to settle a class-action lawsuit in the United States. This lawsuit, brought forth by investors, accused Alibaba of engaging in monopolistic practices. The company's...
Continue Reading
Class Action Alert: Telix Pharmaceuticals Lawsuit Overview
Understanding the Telix Pharmaceuticals Class Action In a significant development, investors of Telix Pharmaceuticals Limited are currently facing a class action lawsuit. This initiative, spearheaded by Bronstein, Gewirtz & Grossman LLC, invites those affected by substantial losses in their investments to take action. The law firm is renowned for its dedication in...
Continue Reading